Post-CDK4/6 Inhibitor Therapeutic Approaches in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Current Evidence and Emerging Strategies—A Narrative Review.
Saved in:
| Title: | Post-CDK4/6 Inhibitor Therapeutic Approaches in Hormone Receptor-Positive, HER2-Negative Metastatic Breast Cancer: Current Evidence and Emerging Strategies—A Narrative Review. |
|---|---|
| Authors: | Al-Shamsi, Humaid O.1,2,3,4,5 (AUTHOR) humaid.al-shamsi@medportal.ca, Abdelwahed, Nadia1,2 (AUTHOR), Abdelwahab, Siddig Ibrahim3,6 (AUTHOR), Hussein, Mawada1,4 (AUTHOR), Abyad, Amin1,5 (AUTHOR), Rafii, Saeed6,7 (AUTHOR), Jaafar, Hassan1,7 (AUTHOR), Otsmane, Sonia1,8 (AUTHOR), Jabbar, Dima Abdul1,9 (AUTHOR), Abdellatif, Hala1 (AUTHOR), Iqbal, Faryal1,2 (AUTHOR), Ahmad, Mudhasir1,3 (AUTHOR), Kourie, Hampig4,8 (AUTHOR), Mokbel, Kefah5,9 (AUTHOR) |
| Source: | Diagnostics (2075-4418). Jun2026, Vol. 16 Issue 12, p1790. 26p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
